Assuming biodefense is required, the following 31 results were found.
-
(USAMRAA) is conducting market research to identify parties capable of modernizing and providing sustained support to the Biodefense Laboratory System (BLMS) system at the U.S. Army Medical Research Institute of Infectious Disease (USAMRIID). BLMS...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
collaboration with Spero, a series of studies to assess the efficacy of SPR994 in the treatment of infections caused by biodefense threats such as anthrax, plague and melioidosis will be conducted by the U.S. Army Medical Research Institute of...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
complexity of biocontainmentlaboratory research activities within the Institute. In an emailed statement to Global Biodefense, the Institute noted it had begun a major re-set of its biological safety program and is working with the CDC on a path...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
infrastructure fails to meet CDC biosafety requirements and has its Federal Select Agent certification pulled? Global Biodefense submitted requests to USAMRIID and the CDC on Aug. 6 for information on the status of the Institute in the LRN structure and...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
underway. Article adapted from original by the Defense Threat Reduction Agency. Edited for context and format by Global Biodefense. Content Original Link: https://globalbiodefense.com/2017/07/31/dod-studies-veriox-countermeasure-deadly-vx-nerve-agent/
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
the keynote lecture. A pioneer in the field of gene therapy with over 117 patents, Wilson spoke on “Vector Platforms for Biodefense and Pandemics.” Since 2002 a highlight of the Bioscience review has been the Clarence A. Broomfield Award lecture, named...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
and Western Equine Encephalitis Viruses in Non-human Primates. Antiviral Research Content Original Link: https://globalbiodefense.com/2022/02/25/usamriid-scientist-wins-amsus-research-and-development/
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
how to submit resumes. Learn more: https://www.facebook.com/events/354326535799511 Content Original Link: https://globalbiodefense.com/event/aberdeen-proving-ground-virtual-career-fair/
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
approach. Scientific Reports, 30 July 2021. Adapted from original story LLNL Content Original Link: https://globalbiodefense.com/2021/10/12/first-in-class-nerve-agent-antidote-crosses-blood-brain-barrier-to-aid-central-nervous-system/
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
Study details are available at https://clinicaltrials.gov/ct2/show/NCT01913353. Content Original Link: https://globalbiodefense.com/2018/02/19/usamriid-leads-successful-smallpox-vaccine-study/
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
monkeypox, which was the first time human monkeypox was reported outside of Africa. Content Original Link: https://globalbiodefense.com/2019/10/20/army-study-leads-to-approval-of-new-smallpox-vaccine/
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
strictly observed. Patients are infectious as long as virus remains in their bodies. Content Original Link: https://globalbiodefense.com/2016/07/14/progress-towards-protection-highly-lethal-ebola-marburg-viruses/
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
the necessary next steps. Sources: Fort Detrick Public Affairs Office, USAMRIID Content Original Link: https://globalbiodefense.com/2018/06/02/usamriid-temporarily-halts-activity-at-bsl-3-and-bsl-4-laboratories/
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys. Content Original Link: https://globalbiodefense.com/2016/03/07/usamriids-small-molecule-antiviral-shows-efficacy-against-ebola/
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
mission. Read the full story by David R. Franz and Judith Miller at City Journal Content Original Link: https://globalbiodefense.com/2020/03/21/usamriid-americas-key-lab-for-fighting-infectious-diseases-has-become-a-pentagon-backwater/
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
develop severe and fatal respiratory disease. JCI Insight, 25 August 2020. Content Original Link: https://globalbiodefense.com/2020/08/27/usamriid-scientists-engineer-first-lethal-mouse-model-for-covid-19/
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
paper were supported by the Biomedical Advanced Research and Development Authority. Content Original Link: https://globalbiodefense.com/2022/02/09/usamriid-study-reveals-ebola-virus-can-hide-in-brain/
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
21 Capabilities Aug 2019 Research Halted at USAMRIID Over Biosafety IssuesAug 2019 Content Original Link: https://globalbiodefense.com/2020/04/01/usamriid-resumes-full-operations-following-federal-select-agent-program-reinstatement/
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
successes.” Adapted from original by Phil Fountain, U.S. Army Futures Command. Content Original Link: https://globalbiodefense.com/2021/07/04/usamriid-scientists-continue-critical-work-against-select-agents-while-aiding-pandemic-response/
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
SPR994 Lawmakers Seek Answers on USAMRIID Shutdown, BioDetection 21 Capabilities Content Original Link: https://globalbiodefense.com/2019/11/23/cdc-approves-partial-resumption-of-usamriid-select-agent-research/
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
Access Non-GMO, antigen-free, FDA-approved antiviral medication formulas used in Moderna's Spikevax.
VirusTC is a retail provider of concentrated FDA-approved antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA-approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.